Valion Bio, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VBIO | TOVX | CLDI | AIM | PMCB | VRAX | |
|---|---|---|---|---|---|---|
| Market cap | 3.27M | 10.07M | 3.49M | 7.08M | 3.92M | 2.49M |
| P/E (TTM) | — | 0.3 | — | — | — | — |
| Forward P/E | — | -1.1 | -1.1 | -0.5 | -1.0 | -0.3 |
| Price/book | 0.1 | 0.8 | 0.6 | 0.7 | 0.1 | 0.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −97.77% | −50.00% | −96.44% | −93.00% | −64.55% | −88.80% |
| Today | −21.50% | +1.11% | −7.78% | −1.44% | −9.72% | −1.07% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All VBIO news ›Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand to Support Data Centers
Rising electricity demand from AI and data centers is driving plans to expand nuclear power capacity, possibly including on-site small modular reactors (SMRs)¹ Medical countermeasures need to scale along with that infrastructure Valion is…
Valion Bio names Melinda Lackey as General Counsel
Valion Bio (VBIO) announced the appointment of Melinda Lackey as General Counsel and Senior Vice President of Legal Affairs. Lackey brings nearl... Valion Bio names Melinda Lackey as General Counsel Valion Bio (VBIO) announced the…
Valion Bio signs $50K preferred share sale agreement
MINERAL EUROPA: A GAME CHANGER FOR SHIPPING The underlying Series B purchase agreement provides for purchases of up to 8,400 preferred shares and up to $8,400,000 in aggregate. On October 7, 2026, Valion Bio, Inc. (VBIO) entered into a…
Valion Bio proposes up to $100M securities offering
The $5,000,000 sales-agreement program is within the shelf, while a one-third sales limit applies when non-affiliate market value is below $75.0 million. The prospectus describes outstanding convertible preferred stock that can dilute…
Valion Bio chair outlines Entolimod development outlook
DarkIris Inc. Announces Pricing of $6 Million Public Offering Valion Bio, Inc. (VBIO) outlined new Board Chair Thomas H. Jensen’s perspectives on advancing Entolimod. Valion Bio, Inc. (VBIO) outlined new Board Chair Thomas H. Jensen’s…
Valion Bio proposes 1-for-2 to 1-for-12 reverse split
MINERAL EUROPA: A GAME CHANGER FOR SHIPPING The proposed split would leave authorized common shares unchanged, while the increase to the equity plan reserve depends on stockholder approval. The third proposal would authorize adjournment to…
Valion Bio completes oral Entolimod formulation
The next milestone is testing for measurable systemic exposure and, if detected, characterizing Entolimod’s absorption profile. Valion Bio, Inc. (VBIO) and Shear Kershman Laboratories completed formulation work on an oral mucosal version…
VBIO Stock Jumps As Valion Bio Resets Leadership And Stabilizes Listing
Valion Bio Inc. stocks have been trading up by 13.43 percent following breakthrough clinical trial results that fueled bullish sentiment. VBIO is trading like a classic low‑float biotech rollercoaster. Over the last couple of weeks, Valion…
VBIO Stock Jumps As Valion Bio Resets Leadership, Regains Nasdaq Compliance
Valion Bio Inc. stocks have been trading up by 23.68 percent following breakthrough clinical trial news boosting investor optimism. VBIO has been trading like a classic small‑cap biotech rollercoaster. Over the last few weeks, Valion Bio…
Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity
Next study will test whether the formulation delivers measurable amounts of Entolimod into the bloodstream "The opportunity we are investigating goes beyond changing how Entolimod is administered," said Dean Zikria, Interim Chief Executive…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
stocktitan.net5
-
stockstotrade.com3
-
timothysykes.com2
-
tradingview.com2
-
bdtonline.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.